Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept
Clinical trial NCT04287348 · TERMINATED
Trial details
- NCT number
- NCT04287348
- Sponsor
- Vista Klinik
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-11-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.